Evidence map›Paper›PMID 39151740›Full record

ArticleJournal of vascular surgery2024

Association of social support and health status outcomes in peripheral artery disease.

Santiago Callegari, Gaëlle Romain, Jacob Cleman, Lindsey Scierka, Poghni A Peri-Okonny, John Spertus, Clementine Labrosciano, John F Beltrame, J Dawn Abbott, Robert Fitridge and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of vascular surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Anxiety and peripheral artery disease.Clinical science (London, England : 1979) · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Santiago CallegariVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
Gaëlle RomainVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
Jacob ClemanVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
Lindsey ScierkaVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
Poghni A Peri-OkonnyVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
John SpertusCardiovascular Research Saint Luke's Mid America Heart Institute Kansas City, Kansas City, MO; Department of Biomedical and Health Informatics of Medicine University of Missouri-Kansas City, Kansas City, MO.
Clementine LabroscianoThe Queen Elizabeth Hospital, Adelaide Medical School, University of Adelaide, Adelaide, Australia.
John F BeltrameSchool of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, Australia.
J Dawn AbbottLifespan Cardiovascular Institute and Division of Cardiology, Department of Medicine, Alpert Medical School of Brown University, Providence, RI.
Robert FitridgeSchool of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, Australia.
Carlos Mena-HurtadoVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT.
Kim G SmolderenVascular Medicine Outcomes Program (VAMOS), Division of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT; Department of Psychiatry, Yale School of Medicine, New Haven, CT. Electronic address: kim.smolderen@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Multi-isotope Hybrid PET/CT/ Imaging of Peripheral Artery Disease in Diabetes: Diversity Supplement Post Doctoral TrainingR01HL163640 · NHLBI · YALE UNIVERSITY · PI Chi Liu, Albert J Sinusas · 2023 to 2026
$3.4M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL163640
6 · The paper itself

Abstract

objectiveA critical goal in the care of patients with peripheral artery disease (PAD) is to optimize their health status; that is, their symptoms, function, and quality of life. Social support has been proposed to be a predictor of disease-specific health status in patients with PAD. However, the prevalence of low perceived social support, the association with health status outcomes, and the interaction with other biopsychosocial variables, is unknown. Our aim was to assess the association of baseline perceived social support with health status at 12 months in patients with PAD.

methodsThe Patient-Centered Outcomes Related Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry, which enrolled patients with PAD in the United States, the Netherlands, and Australia from 2011 to 2015, was used. Perceived social support was assessed at baseline with the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Social Support Inventory (ESSI), and disease-specific (Peripheral Artery Disease Questionnaire [PAQ]) and generic health status (Euro-Quality of Life Visual Analog Scale [VAS] and EQ-5D-3L Index) questionnaires were assessed at baseline and 12 months. Low social support was defined as a score of ≤3 on two items and an ESSI score of ≤18. A hierarchical mixed level linear regression model adjusting for biopsychosocial variables was used to assess the association between low perceived social support and the ESSI score with health status at 12 months.

resultsA total of 949 patients were included (mean age, 67.64 ± 9.32 years; 37.9% female), with low social support being present in 18.2%. Patients with low social support were more likely to not be married or to be living alone (50.0% vs 77.5%; P < .001); have more financial constraints; have more depressive, stress, and anxiety symptoms; and have lower disease-specific and generic health status at baseline and at 12 months. In the unadjusted model, low social support was associated with a -7.02 (95% confidence interval [CI], -10.97 to -3.07) point reduction in the PAQ, -7.43 (95% CI, -10.33 to -4.54) in the VAS, and -0.06 (95% CI, -0.09 to -0.03) in the EQ-5D-3L Index. Adjusting for biopsychosocial factors minimally attenuated these associations (PAQ: -6.52; 95% CI, -10.55 to -2.49; P = .002; VAS: -5.39; 95% CI, 8.36 to -2.42; P < .001; EQ-5D-3L Index: -0.04; 95% CI, -0.07 to 0.01; P = .022). The ESSI per-point score was associated with a decrease of 0.51 (95% CI, 0.18-0.85; P = .003) in PAQ and 0.46 (95% CI, 0.12-0.61; P = .004) in the VAS.

conclusionsAmong patients with PAD, low social support was frequent and associated with a lower health status at 1 year independent of other biopsychosocial variables. Improving social support could improve health status and outcomes in PAD.

Indexed as

Health StatusPeripheral Arterial DiseaseQuality of LifeRegistriesSocial SupportAgedAustraliaFemaleHumansMaleMiddle AgedNetherlandsSurveys and QuestionnairesTime FactorsUnited StatesEQ5DHealth statusPAQ scorePeripheral artery diseaseSocial support

Identifiers

PMID39151740
PMCPMC11585422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.